Skip to content
drillr.ai
Sign up

SILO

Silo Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.33
−4.90%
Ask drillr

  • Aug 19, 2026, 00:00 UTC

    Silo Pharma, Inc. issued 165,000 shares of common stock to Parkview Consulting LLC in a private placement exempt under Section 4(a)(2) of the Securities Act of 1933, with a 12-month lock-up period, as disclosed in an 8-K filed on August 18, 2026.

  • Jul 14, 2026, 12:55 UTC

    Silo Pharma's subsidiary QwikAgents was accepted into Advanced Micro Devices' AMD AI Developer Program.

    Source:

  • Jul 13, 2026, 00:00 UTC

    Silo Pharma, Inc. entered into securities purchase agreements and completed a private placement, selling common shares, pre-funded warrants, and Series A-3/Series A-4 warrants to institutional investors for aggregate gross proceeds of approximately $4,000,015.

  • Jul 7, 2026, 18:18 UTC

    NVIDIA Corp. expanded its presence in life sciences AI through separate initiatives with Certara Inc. and Silo Pharma Inc.

    Source:

  • Jun 18, 2026, 12:12 UTC

    Silo Pharma regained compliance with Nasdaq's minimum bid price requirement as of June 17, 2026.